There were countries that did not recognize pharmaceutical product patents, such as India, and Indian pharmaceutical companies started to produce so-called generic versions, low-cost copies of antiretroviral medicines, and make them available in the developing world, and within a year the price had come down from 10,000 dollars per patient per year to 350 dollars per patient per year, and today that same triple pill cocktail is available for 60 dollars per patient per year,
很多国家并不认可 制药产品专利，拿印度来说， 印度的制药公司 已开始生产所谓的通用配方， 也就是廉价的抗逆转录病毒药品的复制品 以供发展中国家使用 在一年之内，该药品的价格从 每个患者每年一万美元 降到了350美元每个患者每年 直至今天，同样的三联疗法 售价仅为每个患者每年60美元